Filing Details
- Accession Number:
- 0001209191-19-051091
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-30 16:16:22
- Reporting Period:
- 2019-09-27
- Accepted Time:
- 2019-09-30 16:16:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1681682 | Endra Life Sciences Inc. | NDRA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1480371 | R. David Wells | 3600 Green Court, Suite 350 Ann Arbor MI 48105 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-27 | 10,000 | $1.18 | 20,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 24,786 | Indirect | By StoryCorp Consulting |
Billionaire Hedge Funds
